image-cover
業績

業績

[最終更新日 : 2021年3月28日]

私たちは、日常診療のみならず学術活動にも積極的に取り組んでいます。国際共同ならびに全国規模の臨床試験にも多数参加しており、新しい診断・治療法の開発にも携わっております。また、がんの遺伝子検査やロボット手術を含めた新しい医療も提供しています。私たちは、これらの研究成果を学会発表や論文として国内外に発信し、医療の発展に貢献することを目標としています。

最近の学術活動はこちらでご紹介しております。

2020年

題名著者共著者雑誌
癌患者に対する周術期栄養管理やサルコペニア、リハビリテーション療法の意義―感染制御の観点から―本告 正明消化器外科432137-14720202
第3章 10 合併症とその対処法宮﨑 安弘メタボリックサージェリー14020209
スリーブ状胃切除術の基礎研究
-胃縮小効果以外の機序
宮﨑 安弘週刊医学のあゆみ-外科治療と基礎研究の最新情報2741093920209
食道胃接合部扁平上皮癌術後再発に対してオキザリプラチン(L-OHP)を使用し長期間の病態コントロールが得られている1例南壮一郎本告正明、宮崎安弘、西沢佑次郎、小松久晃、井上彬、友國晃、小森孝通、藤谷和正、岩瀬和裕癌と化学療法472310-31220202
術前診断し得た原発性小腸癌に対して腹腔鏡補助下小腸部分切除を施行し得た1例中井 慈人癌と化学療法47131977-1979202012

タイトル筆頭著者共著者雑誌 
Laparoscopic distal gastrectomy for gastric cancer with simultaneous resection of para-aortic schwannomaAtsushi GakuharaYasuhiro Miyazaki, Yukinori Kurokawa, Tsuyoshi Takahashi, Makoto Yamasaki, Tomoki Makino, Koji Tanaka, Masaaki Motoori, Yutaka Kimura, Kiyokazu Nakajima, Shuji Takiguchi, Masaki Mori, Yuichiro DokiAsian Journal of Endoscopic Surgery2020113195-98
miR-4711-5p regulates cancer stemness and cell cycle progression via KLF5, MDM2 and TFDP1 in colon cancer cellsYoshihiro MorimotoTsunekazu Mizushima, Xin Wu, Daisuke Okuzaki, Yuhki Yokoyama, Akira Inoue, Tsuyoshi Hata, Haruka Hirose, Yamin Qian, Jiaqi Wang, Norikatsu Miyoshi, Hidekazu Takahashi, Naotsugu Haraguchi, Chu Matsuda, Yuichiro Doki, Masaki Mori, and Hirofumi YamamotoBritish Journal of Cancer20202published online
Prognostic Impact of Postoperative Complications following Salvage Esophagectomy for Esophageal Cancer after Definitive ChemoradiotherapyKeijiro SugimuraHiroshi Miyata, Naoki Shinno, Hajime Ushigome, Kei Asukai, Hisashi Hara, Shinichiro Hasegawa, Daisaku Yamada, Kazuyoshi Yamamoto, Naotsugu Haraguchi, Junichi Nishimura, Masaaki Motoori, Hiroshi Wada, Hidenori Takahashi, Masayoshi Yasui, Takeshi Omori, Masayuki Ohue, Masahiko YanoOncology20203985280-288
What is the most useful body composition parameter for predicting toxicities of preoperative chemotherapy for gastric cancer?Tadayoshi HashimotoYukinori Kurokawa, Tsuyoshi Takahashi, Takuro Saito, Kotaro Yamashita, Koji Tanaka, Tomoki Makino, Makoto Yamasaki, Masaaki Motoori, Yutaka Kimura, Kiyokazu Nakajima, Masaki Mori, Yuichiro DokiSurgery Today2020550509-515
Tracheal resection and anterior mediastinal tracheostomy in the multidisciplinary treatment of esophageal cancer with tracheal invasion.Makoto Yamasaki Kotaro Yamashita, Takuro Saito, Koji Tanaka, Tomoki Makino, Yasuhiro Miyazaki, Tsuyoshi Takahashi, Yukinori Kurokawa, Kiyokazu Nakajima, Masaaki Motoori, Yutaka Kimura, Masaki Mori, Yuichiro DokiDis Esophagus20205335published online
The Pattern of Residual Tumor After Neoadjuvant Chemotherapy for Locally Advanced Esophageal Cancer and Its Clinical SignificanceTadayoshi HashimotoTomoki Makino, Makoto Yamasaki, Koji Tanaka, Yasuhiro Miyazaki, Tsuyoshi Takahashi, Yukinori Kurokawa, Masaaki Motoori, Yutaka Kimura, Kiyokazu Nakajima, Eiichi Morii, Masaki Mori, and Yuichiro DokiAnnals of Surgery202052715875-884
Differences in disease status between patients with progression after first-line chemotherapy versus ealry relapse after adjuvant chemotherapy who undergo scond-line chemotherapy for gastric cancer: Exploratory analysis of the randomized phaseⅢ TRICS trialK.NishikawaK.Murotani, K.Fujitani, H.Inagaki, Y.Akamaru, S.Tokunaga, M.Takagi, S.Tamura, N.Sugimoto, T.Shigematsu, T.Yoshikawa, T.Ishiguro, M.Nakamura, H.Hasegawa, S.Morita, Y.Miyashita, S,Tsuburaya, J.Sakamoto, T.TsujinakaEur J Cancer 20206132159-167
Adjuvant Chemotherapy after Neoadjuvant Chemotherapy and Long-term Outcomes of CAPOX Plus Bevacizumab Followed by TME for High-risk Localized Rectal Cancer.Nishimura JHasegawa J, Noura S, Ikeda K, Yasui M, Komori T, Tsujie M, Yasumasa K, Shingai T, Uemura M, Hata T, Matsuda C, Mizushima T, Ikeda M, Doki Y, Mori M,J Anus Rectum Colon2020743108-113
Efficacy of Negative Pressure Wound Therapy Followed by Delayed Primary Closure for Abdominal Wounds in Patients with Lower Gastrointestinal Perforations: Multicenter Prospective Study.Ota HDanno K, Ohta K, Matsumura T, Komori T, Okamura S, Okano M, Ogawa A, Tamagawa H,Uemura M, Matsuda C,Mizushima T, Yamamoto H, Nezu R, Doki Y, Eguchi HJ Anus Rectum Colon2020743114-121
Randomized Comparison of Gastric Tube Reconstruction With and Without Duodenal Diversion Plus Roux-en-Y Anastomosis After EsophagectomyMasahiko YanoKeijiro Sugimura, Hiroshi Miyata, Masaaki Motoori ,Koji Tanaka, Takeshi Omori, Masayuki Ohue, and Masato SakonAnnals of Surgery20207272148-54
Multicentre biomarker cohort study on the efficacy of nivolumab treatment for gastric cancerT.HagiY.Kuroawa, R.Kawabata, T.Omori, J.Matsuyama, K.Fujitani, M.Hirao, Y.Akamaru, T.Takahashi, M.Yamasaki, T.Sato, H.Eguchi and Y.DokiBr J Cancer202071236965-972
Survival analysis of a prospective multicenter observational study on surgical palliation among patients receiving treatment for malignant gastric outlet obstruction caused by incurable advanced gastric cancerTerashima MFujitani K, Ando M, Sakamaki K, Kawabata R, Ito Y, Yoshikawa T, Kondo M, Kodera Y, Kaji M, Oka Y, Imamura H, Kawada J, Takagane A, Shimada H, Tanizawa Y, Yamanaka T, Morita S, Ninomiya M, Yoshida KGastric Cancer20208e-pub
Analysis of prognostic factors in patients with lymph node recurrence after radical esophagectomy: importance of locoregional therapyKoji TanakaMakoto Yamasaki, Tomoki Makino, Kotaro Yamashita, Takuro Saitoh, Tsuyoshi Takahashi, Yukinori Kurokawa, Kiyokazu Nakajima, Masaaki Motoori, Yutaka Kimura, Masayuki Mano, Masaki Mori, Hidetoshi Eguchi,Yuichiro DokiEsophagus20209published online
Comparison of S-1-cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trialsH.KawakamiK. Fujitani, J.Matsuyama, Y. Akamaru, S.Tamura, S.Endo, Y.Kimura, Y.Makari, T.Tamura, N.Sugimoto, D.Sakai, T. Tsujinaka, M.Goto, Y.Kurokawa , T.Shimokawa, T.Satoh Int J Clin Oncol20209251635-1643
Somatic mutation distributions in cancer genomes vary with three-dimensional chromatin structureKadir C AkdemirVictoria T.Le, Justin M. Kim, Sarah Killcoyne, Devin A. King, Ya-Ping Lin, Yanyan Tian, Akira Inoue, Samirkumar B.Amin, Frederick S. Robinson, Manjunath Nimmakayalu, Rafael E. Herrera, Erica J. Lynn, Kin Chan, Sahil Seth, Leszek J. Klimczak, Moritz Gerstung, Dmitry A. Gordenin, John O'Brien, Lei Li, Yonathan Lissanu Deribe, Roel G. Verhaak, Peter J. Campbell, Rebecca Fitzgerald, Ashby J. Morrison, Jesse R. Dixon and P. Andrew FutrealNature Genetics202010published online
Multicenter Randomized Phase 2 Trial Comparing Chemoradiotherapy and Docetaxel Plus 5-Fluorouracil and Cisplatin (DCF) Chemotherapy as Initial Induction Therapy for Subsequent Conversion Surgery in Patients with Clinical T4b Esophageal Cancer: Short-term ResultsK.SugimuraH.Miyata, K.Tanaka, T.Makino, A.Takeno, O.Shiraishi, M. Motoori, M.Yamasaki, Y.Kimura , M.Hirao, K.Fujitani, T.Yasuda, M.Mori, H.Eguchi, M.Yano, Y.Doki Ann Surg202010e-pub
Loss of ARID1A promotes epithelial-mesenchymal transition and sensitizes pancreatic tumors to proteotoxic stressHideo TomiharaFederica Carbone, Luigi Perelli, Justin K. Huang, Melinda Soeung, Johnathon L. Rose, Frederick S. Robinson, Yonathan Lissanu Deribe, Ningping Feng, Mitsunobu Takeda, Akira Inoue, Angela K. Deem, Anirban Maitra, Pavlos Msaouel, Nizar M. Tannir, Giulio F. Draetta, Christopher A. Bristow, Alessandro Carugo, and Giannicola GenoveseCancer Reseach202011published online
Correlation between Skeletal Muscle Mass and Adverse Events of Neoadjuvant Chemotherapy in Patients with Gastric CancerNorihiro MatsuuraMasaaki Motoori, Kazumasa Fujitani, Yujiro Nishizawa, Hisateru Komatsu, Yasuhiro Miyazaki, Susumu Miyazaki, Akira Tomokuni, Takamichi Komori, Kazuhiro IwaseOncology202098129-34
Meta-analysis of two randomaized phase Ⅲ trials(TCOG GI-0801 and ECRIN TRICS) of biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancerK.NishikawaW.Koizumi, A.Tsuburaya, T.Yamanaka, S.Morita, K.Fujitani, Y.Akamaru, K.Shimada, H.Hosaka, N.Nakayama, T.Tsujinaka, J.SakamotoGastric Cancer2020231160-167
Is it Necessary to Confirm Negative Margins in Gastrectomy for Peritoneal Lavage Cytology-positive Gastric Cancer?S.EndoY.Fujiwara, T.Yamatsuji, K.Nishikawa, K.Fujitani, M.Ikenaga, J.Kawada, Y.Okamoto, H.Kubota, M.Higashida, T.UenoAnticancer Res202040105807-5813
A Phase II trial of dose-reduced nab-paclitaxel for patients with previously treated,advanced or recurrent gastric cancer (OGSG1302)S.TamuraH.Taniguchi, K.Nishikawa, H.Imamura, J.Fujita, A.Takeno, J.Matsuyama, Y.Kimura, J.Kawada, M.Hirao, M.Hirota, K.Fujitani, Y.Kurokawa, D.Sakai, H.Kawakami, T.Shimokawa, T.SatohInt J Clin Oncol202025122035-2043
Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subgroup analysis of the JACOB trialK.Shitara H.Hara, T.Yoshikawa, K.Fujitani , T.Nishina, A.Hosokawa, T.Asakawa, S. Kawakami, K.MuroInt J Clin Oncol2020252301-311
Primary results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S-1 and docetaxel/cisplatin/S-1 as neoadjuvant chemotherapy for advanced gastric cancerT.HayashiT.Yoshikawa, K.Sakamaki,  K.Nishikawa, K.Fujitani,  K.Tanabe, K.Misawa, T.Matsui, A.Miki, H.Nemoto, T.Fukunaga, Y.Kimura, J. HiharaAnn Gastroenterol Surg202045540-548
A Phase II Study of Perioperative Capecitabine plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601)T.TerazawaJ.Matsuyama, M.Goto, R. Kawabata, S.Endo, M.Imano, S.Fujita, Y.Akamaru, H. Taniguchi, M.Tatsumi, SW Lee , Y.Kurisu, H.Kawakami, Y. Kurokawa, T.Shimokawa, D.Sakai, T.Kato, K.Fujitani, T.SatohOncologist2020252119-e208
Docetaxel plus S-1 versus cisplatin plus S-1 in unresectable gastric cancer without measurable lesions:a randomized phase II trial (HERBIS-3)Y.KurokawaJ.Matsuyama, K.Nishikawa, A.Takeno, Y.Kimura, K.Fujitani, R.Kawabata, Y.Makari, T.Terazawa,H.Kawakami, D.Sakai, T.Shimokawa, T.SatohGastric Cancer2020e-pub
Multicenter prospective trial of total gastrectomy versus proximal gastrectomy for upper third cT1 gastric cancerM.Yamasaki S Takiguchi, T Omori, M Hirao, H Imamura, K Fujitani, S Tamura, Y Akamaru, K Kishi, J Fujita, T Hirao, K Demura, J Matsuyama , A Takeno, C Ebisui, K Takachi, O Takayama, H Fukunaga, K Okada, S Adachi, S Fukuda, N Matsuura, T Saito, T Takahashi , Y Kurokawa, M Yano, H Eguchi, Y DokiGastric Cancer2020e-pub
A Randomized Phase II Study to Evaluate Prolonged Prophylactic Antibacterial Drug Treatment for Patients with Elevated Drain Amylase Concentration After Gastrectomy with D2 Lymph Node Dissection (REDUCED2)Y.MikiM.Tokunaga, K.Mori, N.Fukushima, K.Misawa, K.Nishikawa, K.Fujitani, M.Ohira, Y.Tanizawa, E.Bando, M.TerashimaWorld J Surg2020e-pub
Patient-reported symptom burden as a prognostic factor in treatment with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trialOoki AMorita S, Iwamoto S, Hara H, Tanioka H, Satake H, Kataoka M, Kotaka M, Kagawa Y, Nakamura M, Shingai T, Ishikawa M, Miyake Y, Suto T, Hashiguchi Y, Yabuno T, Sakamoto J, Tsuji A, Ando M, Yamaguchi K.Cancer Medicine20203951779-1789
Phase II Study of Panitumumab Monotherapy in Chemotherapy-Naive Frail or Elderly Patients with Unresectable RAS Wild-Type Colorectal Cancer: OGSG 1602Terazawa TKato T, Goto M, Ohta K, Noura S, Satake H, Kagawa Y, Kawakami H, Hasegawa H, Yanagihara K, Shingai T, Nakata K, Kotaka M, Hiraki M, Konishi K, Nakae S, Sakai D, Kurokawa Y, Shimokawa T, Satoh T.The Oncologist20209 doi: 10.1002/ONCO.13523. Online ahead of print.
FMS-like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancerHasegawa HTaniguchi H, Nakamura Y, Kato T, Fujii S, Ebi H, Shiozawa M, Yuki S, Masuishi T, Kato K, Izawa N, Moriwaki T, Oki E, Kagawa Y, Denda T, Nishina T, Tsuji A, Hara H, Esaki T, Nishida T, Kawakami H, Sakamoto Y, Miki I, Okamoto W, Yamazaki K, Yoshino T.Cancer Science2020101121314-322
Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studiesNakamura YTaniguchi H, Ikeda M, Bando H, Kato K, Morizane C, Esaki T, Komatsu Y, Kawamoto Y, Takahashi N, Ueno M, Kagawa Y, Nishina T, Kato T, Yamamoto Y, Furuse J, Denda T, Kawakami H, Oki E, Nakajima T, Nishida N, Yamaguchi K, Yasui H, Goto M, Matsuhashi N, Ohtsubo K, Yamazaki K, Tsuji A, Okamoto W, Tsuchihara K, Yamanaka T, Miki I, Sakamoto Y, Ichiki H, Hata M, Yamashita R, Ohtsu A, Odegaard JI, Yoshino T.Nature Medicine20201226121859-1864
Phase Ib/II Study of Biweekly TAS-102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study)Satake HKato T, Oba K, Kotaka M, Kagawa Y, Yasui H, Nakamura M, Watanabe T, Matsumoto T, Kii T, Terazawa T, Makiyama A, Takano N, Yokota M, Okita Y, Matoba K, Hasegawa H, Tsuji A, Komatsu Y, Yoshino T, Yamazaki K, Mishima H, Oki E, Nagata N, Sakamoto J.Oncologist2020122512e1855-e1863
Phase II Study of Panitumumab Monotherapy in Chemotherapy-Naïve Frail or Elderly Patients with Unresectable RAS Wild-Type Colorectal Cancer: OGSG 1602Terazawa TKato T, Goto M, Ohta K, Noura S, Satake H, Kagawa Y, Kawakami H, Hasegawa H, Yanagihara K, Shingai T, Nakata K, Kotaka M, Hiraki M, Konishi K, Nakae S, Sakai D, Kurokawa Y, Shimokawa T, SatohOncologist2020Jan.261e17-e47
Posttherapy topographical nodal status, ypN-site, predicts survival of patients who received neoadjuvant chemotherapy followed by curative surgical resection for non-type 4 locally advanced gastric cancer: supplementary analysis of JCOG 1004-AK.FujitaniK.Nakamura, J.Mizusawa, T.Kuwata, T.Shimoda, H.Katayama, R.Kushima, H.Taniguchi, T.Yoshikawa, N.Boku, M.Terashima, H.Fukuda. M.Sasako Gastric Cancer20201e-pub
Five-year outcomes of a phaseⅡstudy of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)K.FujitaniS.Tamura, Y.Kimura, J.Matsuyama, H.Imamura, K.Yamamoto, J.Fujita, S Iijima, S.Ueda, Y.Kurokawa, T.Shimokawa, T.SatohGastric Cancer20205233520-530
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trialK.FujitaniK.Shitara,A.Takashima, K,Kodeda, H.Hara, N.Nakayama, S.Hironaka, K.Nishikawa, Y.Kimura, K.Amagai, H.Hosaka, Y.Komatsu,K.Shimada, R.Kawabata, H.Ohdan, Y.Kodera, M.Nakamura, T.Eguchi Nakajima, Y.Miyata, T.Moriwaki, T.Kusumoto, K.Nishikawa, K.Ogata, M.Shimura, S.Morita, W.KoizumiGastric Cancer202011e-pub
Impact of preoperative fecal short chain fatty acids on postoperative infections complications in esophageal cancer patientsM.MotooriK.Tanaka, K.Sugimura, H.Miyata, T.Saito, Y.Miyazaki, K.Fujitani, Y.Kado, T.Asahara, M.YanoBMC Gastroenterol2020320174
Open versus laparoscopic surgery for primary appendiceal tumors: a large multicenter retrospective propensity score-matched cohort study in JapanAkira InoueKohei Murata, Takamichi Komori, Takashi Takeda, Makoto Fujii, Tomohiro Yamaguchi, Tatsuro Yamaguchi, Toshiki Masuishi, Tetsuya Shiota Shunji Morita, Yozo Suzuki, Masaaki Ito, Yukihide Kanemitsu, Manabu Shiozawa, Masayoshi Yasui, Yoshinori Kagawa, Kenichi Sugihara,Surgical Endoscopy20209published online

2019年

題名著者共著者雑誌
癌患者の周術期における感染制御を目的とした栄養管理本告正明外科と代謝・栄養53289-9520194
全身化学療法後にConversion Surgeryを施行し得た切除不能膵腺扁平上皮癌の1例小松久晃柏﨑正樹、長谷川徳子、西沢佑次郎、中塚梨絵、宮﨑進、小森孝通、本告正明、薬師神祟行、伏見博彰、藤谷和正、岩瀬和裕癌と化学療法463546-54820193
食道癌・胃癌術後の膵頭部癌に対し膵頭十二指腸切除を施行した1例杉本智樹小松久晃、西沢佑次郎、井上彬、宮﨑安弘、小森孝通、本告正明、友國晃、藤谷和正、岩瀬和裕癌と化学療法46132464-2466 201912
肝切除を施行した胆管内乳頭状腫瘍(IPNB)の2例池永直樹小松久晃、西沢佑次郎、井上彬、宮﨑安弘、小森孝通、本告正明、友國晃、伏見博彰、藤谷和正、岩瀬和裕癌と化学療法46132398-2400201912

タイトル筆頭著者共著者雑誌
A study of second-line irinotecan plus cisplatin vs. irinotecan alone in platinum-naïve paients with early relapse of gastric cancer refractory to adjuvant S-1 monotherapy:exploratory subgroup analysis of the randomaized phaseⅢ TRICS trialK.NishikawaK.Murotani, K.Fujitani,H.Inagaki, Y.Akamaru, S.Tokunaga, M.Takagi, S.Tamura, N.Sugimoto, T.Shigematsu, Y.Miyashita, A.Tsuburaya, J.Sakamoto, T.TsujinakaCancer Chemotherapy and Phamacology2019835867-874
Sarcopenia Is Associated With Impaired Overall Survival After Gastrectomy for Elderly Gastric CancerK.YamamotoM.Hirao, K.Nishikawa, T.Omori, Y.Yanagimoto, N.Shinno, K.Sugimura, H.Miyata, H.Wada, H.Takahashi, M.Yasui, M.Yano, K.Fujitani and T.TsujinakaAnticancer Research2019394297-4303
Questionnaire survey on adjuvant chemotherapy for elderly patients after gastrectomy indicates their vulnelabilitiesT.TanahashiK.Yoshida, K.Yamaguchi, N.Okumura, A.Takeno, K.Fujitani, N.Fukushima, N.Takiguchi, Y.Nishida, N.Boku, T.Yoshikawa, M.TerashimaGastric Cancer201922130-137
Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phaseⅢABSOLUTE trialA.TakashimaK.Shitara, K.Fujitani, K.Koeda, H.Hara, N.Nakayama, S.Hironaka, K.Nishikawa, Y.Kimura, K.Amagai, H.Fujii, K.Muro, T.Esaki, Y.Choda, T.Takano, K.Chin, A.Sato, M.Goto, N.Fukushima, T.Hara, M.Machida, M.Ohta, N.Boku, M.Shimura, S.Morita, W.KoizumiGastric Cancer201922155-163
Effects of perioperative Eicosapentaenoic acied-enriched oral nutritional supplement on lean body mass after total gastrectomy for gastric cancerT.AoyamaT.Yoshikawa, H.Cho, K.Sakamaki, Y.Ito, K.Fujitani, N.Takiguchi, Y.Kawashima, K.Nishikawa, T.Oshima, S.Nunobe, N.HikiJournal of Cancer20191051070-1076
Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy Subgroup Analyses of a Randomized Clinical TrialD.H.IlsonJ.Tabemero, A.Prokharau, H.T.Arkenau, M.Ghidini, K.Fujitani, E.V.Cutsem, P.T.Patience, G.D.Beretta, W.Mansoor, E.Zhavrid, M.Alsina, D.Catenacci, S.McGuigan, L.Makris, T.Doi,K.ShitaraJAMA Onclogy2019Epub
A phaseⅡ Study of Perioperative Capecitabine Plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer(OGSG1601)T.TerasawaJ.Matsuyama, M.Goto, R.Kawabata,S.Endo, M.Imano, S.Fujita, Y.Akamaru,H.Taniguchi,M.Tatsumi, S.W.Lee, Y.Kurisu, H.Kawakami, Y.Kurokawa, T.Shimokawa,D.Sakai,T.Kato, K.Fujitani, T.SatohThe Oncologist2019Epub
Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastirc or gastroesophageal junction cancer: a subgroup analysis of the JACOB trialK.ShitaraH.Hara, T.Yoshikawa, K.Fujitani, T.Nishida, A.Hosokawa, T.Asakawa, S.Kawakami, K.MuroInternational Journal of Clinical Oncology2019Epub
Five-year outcomes of a phaseⅡstudy of adjuvant chemotherapy with S-1 plus docetaxel for stageⅢgastric cancer after curative D2 gastrectomy(OGSG1002)K.FujitaniS.Tamura, J.Matsuyama, H.Imamura, K.Yamamoto,J.Fujita,S.Iijima,S.Ueda, Y.Kurokawa,T.Shimokawa,T.Satoh Gastric Cancer2019Epub
Skeletal Muscle Loss during Neoadjuvant Chemotherapy Is an Independent RiskFactor for Postoperative Infectious Complications in Patients with Advenced Esophageal CancerM.MotooriK.Fujitani, K.Sugimura H.Miyata, R.Nakatsuka, Y.Nishizawa, H.Komatsu, S.Miyazaki, T.Komori, M.Kashiwazaki, K.Iwase, M.YanoOncolgy201995281-287
Impact of Age on Long-Term Survival in Patients with Esophageal Cancer Who Underwent Transthoracic Esophagectomy.Motoori MIto Y, Miyashiro I, Sugimura K,Miyata H, Omori T, Fujiwara Y, Yano M, Oncolgy20196973149-154
Current and Future Horizons of Patient-Derived Xenograft Models in Colorectal Cancer Translational ResearchAkira InoueAngela K. Deem, Scott Kopetz, Timothy P. Heffernan, Giulio F. Draetta, and Alessandro CarugoCancers201991192019-01-24 00:00:00

2018年

題名著者共著者雑誌
直腸癌局所再発に対して術前放射線化学療法を施行し切除した2例長束佑太團野克樹、宮崎進、小森孝通、中塚梨絵、小松久晃、本告正明、柏崎正樹、藤谷和正、岩瀬和裕、後藤満一癌と化学療法454752-75420184
巨大嚢胞を伴った遊走脾に対して待機的手術を施行した1例北川彰洋松田宙、中塚梨絵、宮崎進、團野克樹、本告正明、久保田勝、伏見博彰、藤谷和正、岩瀬和裕日本消化器外科学会雑誌512132-13720182
2次性大動脈十二支腸瘻の3症例松浦記大藤谷和正、中塚梨絵、宮﨑進、團野克樹、小森孝通、本告正明、柏﨑正樹、岩瀬和裕日本消化器外科学会雑誌516406-41420181
stageⅣ胃癌に対する減量手術藤谷和正辻仲利政日本医事新報489724-2920183
直径15㎝の巨大な腸間膜裂孔による絞扼性イレウスの1例野口侑記吉田洋日本小児外科学会雑誌544946-9502018

タイトル筆頭著者共著者雑誌 
A phase Ⅱ study of nb-paclitaxel in combination with ramusirumab in patients with previously treated advanced gastric cancerH.BandoH.Shimodaira, K.Fujitani, A.Takashima, K.Yamaguchi, N.Nakayama, T.Takahashi, E.Oki, M.Azuma, T.Nishina, S.Hironaka, Y.Komatsu, K.ShirotaEuro J of Cancer20189186-91
Ramucirumab for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first-line platinum-or fluoropyrimidine-containing combination therapy in Japanese patients:a phase 2, open-label studyK.YamaguchiK.Fujitani, F.Nagashima, Y.Omuro, N.Machida, T.Nisina, T.Koue M.Tsujimoto, K.Maeda, T.SatohGastric Cancer20182161041-1049
A phaseⅡ trial of capeciabine plus cisplatin(XP)for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy:XParTS-1 trialK.NishikawaA.Tsuburaya, T.Yoshikawa, M.Takahashi, K.Tanabe, K.Yamaguchi, S.Yoshino, T.Namikawa, T.Aoyama, Y.Rino, J.Kawada, N.Hirabayashi, K.Fujitani, Y.Miyashita, S.Morita, J.SakamotoGastric Cancer2018215811-818
A randomized phase Ⅱmulticenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence:final results of the INPACT trialN.TakahashiM.Kanda, T.Yoshikawa, N.Takiguchi, K.Fujitani, K.Miyamoto, Y.Ito, O,Takayama, M.Imano, N.Mitsumori, J.Sakamoto, S.Morita, Y.KoderaGastric Cancer2018211014-1023
Randomized, Open-Label Phase ⅡStudy Comparing Capecitabine-Cisplatin Every 3 Weeks with S-1-Cisplatin Every 5 Weeks in Chemotherapy-Naïve Patients with HER2-Negative Advanced Gastir Cancer:OGSG1105,HERBIS-4A TrialH.KawakamiA.Takeno, S.Endo, Y.Makari, J.Kawada, H.Taniguchi, S.Tamura, M.Sugimoto, Y.Kimura, T.Tamura, K.Fujitani, D.Sakai, T.Shimokawa, Y.Kurokawa, T.SatoThe Oncologist2018231-9
Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer(TAGS):a randomised, double-blind,placebo-controlled, phase 3 trialK.ShitaraT.Doi, M.Dvorkin, W.Mansoor, H-T.Arkenau, A.Prokharau, M.Alsina, M.Fhidini, C.Faustino, V.Gorbunova, E.Zhavrid, K.Nishikawa, A.Hosokawa, S.Yalcin, K.Fujitani, G.D. Beretta, E.V. Cutsem, R.E. Winkler L.Makris, D.H.Ilson, J.TaberneroLancet Oncolgy2018191437-1448
Questionnaire survey on adjuvant chemotherapy for elderly patients after gastrectomy indicates their vulnelabilitiesT.TanahashiK.Yoshida, K.Yamaguchi, N.Okumura, A.Takeno, K.Fujitani, N.Fukushima, N.Takiguchi, Y.Nishida, N.Boku, T.Yoshikawa, M.TerashimaGastric Cancer2018in press
Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phaseⅢABSOLUTE trialA.TakashimaK.Shitara, K.Fujitani, K.Koeda, H.Hara, N.Nakayama, S.Hironaka, K.Nishikawa, Y.Kimura, K.Amagai, H.Fujii, K.Muro, T.Esaki, Y.Choda, T.Takano, K.Chin, A.Sato, M.Goto, N.Fukushima, T.Hara, M.Machida, M.Ohta, N.Boku, M.Shimura, S.Morita, W.KoizumiGastric Cancer2018in press
Time to initiation or duration of S-1 adjuvant chemotherapy; which really impacts on survival in stageⅡandⅢgastric cancer?K.FujitaniY.Kurokawa, A.Takeno, S.Endoh, M.Yamasaki, S.Takiguchi, M.Mori, Y.Doki: On behalf of the Osaka University Cllnical Research GroupGastric Cancer201821446-452
Efficacy of Negative-Pressure Wound Therapy for Preventing Surgical Site Infections after Surgery for Peritonitis Attributable to Lower-Gastrointestinal Perforation: A Single-Institution ExperienceKatsuki DannoChu Matsuda, Susumu Miyazaki, Takamichi Komori, Megumi Nakanishi, Masaaki Motoori, Masaki Kashiwazaki, and Kazumasa FujitaniSURGICAL INFECTIONS20181902019-01-05 00:00:00
Skeletal Muscle Loss during Neoadjuvant Chemotherapy Is an Independent Risk Factor for Postoperative Infectious Complications in Patients with Advanced Esophageal CancerMasaaki MotooriKazumasa Fujitani, Keijiro Sugimura, Hiroshi Miyata, Rie Nakatsuka, Yujiro Nishizawa, Hisateru Komatsu, Susumu Miyazaki, Takamichi Komori, Masaki Kashiwazaki, Kazuhiro Iwase, Masahiko YanoOncology2018895281-287
Distinct Clinical Factors in Hospitalized Patients with Diverticular Bleeding and DiverticulitisMakiko UrabeTsutomu Nishida, Hiromi Shimakoshi, Akiyoshi Shimoda, Takahiro Amano, Aya Sugimoto, Kei Takahashi, Kaori Mukai, Tokuhiro Matsubara, Masashi Yamamoto, Shiro Hayashi, Sachiko Nakajima,Koji Fukui,Tsukasa Tanida, Takamichi Komori, Shunji Morita, Masami InadaDigestion201892019-01-08 00:00:00

2017年

題名著者共著者雑誌開始頁終了頁
当院におけるレゴラフェニブの使用経験からみた推奨する投与法松田宙團野克樹、宮崎進、藤谷和正、久保田勝、本告正明、中塚梨絵、西村正成、北川彰洋、高木麻里、岩瀬和裕癌と化学療法441475120171
サルコペニアを有する高齢胃癌患者に対する新しい取組み~「術前栄養+エクササイズプログラム」の概要山本和義長妻佑季子、福田泰也、西川和宏、平尾素宏、鳥山明子、中原千尋、宮本敦史、中森正二、関本貢嗣、藤谷和正、辻仲利政外科と代謝・栄養51417518120178
消化管穿孔を伴った最大径45cmの腸間膜由来脱分化型脂肪肉腫の1例野村雅俊藤谷和正、川田純司、伏見博彰、松田宙、岩瀬和裕日本臨床外科学会誌787161716222017
消化器疾患・高度侵襲時における
シンバイオティクス療法の有用性
本告正明臨床外科72332332820173
サルベージ食道切除後に遅発性縫合不全を起こした食道癌の1例在田麻美本告正明、中塚梨絵、長束佑太、岩瀬和裕、藤谷和正日本臨床外科学会誌7810222022242017
直腸癌横隔膜転移に対し外科的切除を施行した一例林芳矩團野克樹、宮崎進、小森孝通、小松久晃、中塚梨絵、本告正明、柏﨑正樹、藤谷和正、岩瀬和裕、後藤満一癌と化学療法4412140814102017
ロタウイルスワクチン接種後に腸重積症を発症し腸切除を要した1例東尾篤史高間勇一、三藤賢志、中岡達雄、米田光宏、中村哲郎日本小児外科学会雑誌5322722762017

タイトル筆頭著者共著者雑誌 
Fasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trialY.KoderaN.Takahashi, T.Yoshikawa, N.Takiguchi, K.Fujitani, Y.Ito, K.Miyamoto, O.Takayama, M.Imano, D.Kobayashi, Y.Miyashita, S.Morita, J.SakamotoGastric Cancer2017201190-199
Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric CarcinomaT.SanoM.Sasako, J.Mizusawa, S.Yamamoto, H.Katai, T.Yoshikawa, A.Nashimoto, S.Ito, M.Kaji, H.Imamura, N.Fukushima, and K.FujitaniAnnal of Surgery20172652277-283
Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer(ABSOLUTE):an open-label,randomised,non-inferiority,phase 3 trialK.ShitaraA.Takashima K. Fujitani, K.Koeda, H.Hara, N.Nakayama, S.Hironaka, K.Nishikawa, Y.Makari, K.Amagai, S.Ueda, K.Yoshida, H.Shimodaira, T.Nishina, M.Tsuda, Y.Kurokawa,T.Tamura, Y.Sakai, S.Morita, W.KoizumiLancet Gastroenterol Hepatol201724277-287
Fesibiity of Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil versus Adriamycin, Cisplatin, and 5-Fluorouracil for Resectable Advanced Esophageal CancerO.ShiraishiM.Yamasaki, T.Makino, M.Motoori, H.Miyata, M.Shinkai, Y.Kimura, M.Hirao, K.Fujitani, S.Tamura, K.Kobayashi, M.Yano, Y.Doki, T.YasudaOncology2017922101-108
Randomized Controlled Trial of Adjuvant Chemotherapy with Fluoropyrimidines Versus Surgery-alone for Gastric CancerJ.H MoonY.Fujiwara, M. Hirao, H.Imamura, Y.Kimura, L.Fujitani, J.Fujita, S.Tamura, S.Takiguchi, M.Yano, M.Mori and Y.DokiAnticancer Res20173763061-3067
Meta-analysis of patient-level data on biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer with the TCOG GO-0801 BIRIP TRICS RCTs:protocol paperK.NisikawaW.Koizumi, A.Tsuburaya, T.Yamanaka, S.Morita, K.Fujitani, Y Akamaru, K,Shimada, H.Hosaka, N.Nakayama,T.Tsujinaka, J.SakamotoAnn Cancer Res Ther201725244-51
Effectiveness of a preoperative exercise and nutritional support program for elderly sarcopenic patients with gastric cancerK.YamamotoY.Nagatsuma, Y.Fukuda, M.Hirao, K.Nisikawa, A.Miyamoto, M.Ikeda, S.Nakamori, M.Sekimoto, K.Fujitani, T.TsujinakaGastric Cancer2017205913-918
Early results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S-1 and docetaxel/cisplatin/S-1 as neoadjuvant chemotherapy for locally advanced gastric cancer.T. AoyamaK.Nishikawa, K.Fujitani, K.Tanabe, S.Ito, T.Matsui, A.Miki, H.Nemoto, K.Sakamaki, T.Fukunaga, Y.Kimura, N.Hirabayashi and T.YoshikawaAnn Oncol20172881876-1881
Randomized clinical trial comparing standard diet with perioperative oral immunonutrition in total gastrectomy for gastric cancer
S.IdaN.Hiki, H.Cho, K.Sakamaki, S.Ito, K.Fujitani, N.Takiguchi, Y.Kawashima, M.Sasako, T.Aoyama, M.Honda, T.Sato, S.Nunobe, T.YoshikawaBr J Surg20171044377-383
Multicenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus Adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003).
M.YamasakiT.Yasuda, M.Yano, M.Hirao, K.Kobayashi, K.Fujitani, S.Tamura, Y.Kimura, H.Miyata, M.Motoori, O.Shiraishi, T.Makino, T.Satoh, M.Mori, Y.DokiAnn Oncol2017281116-120
Clinicopathological features of neuroblastic tumors with opsoclonus-myoclonus-ataxia syndrome: Follicular structure predicts a better neurological outcome.Hiroko FukushimaTakeshi Inoue, Yuichi Takama, Naomi Ishii, Takahiro Okuno, Yasutsugu Kobayashi, Akihiro Yoneda, Tetsuro Nakamura, Ichiro Kuki, Junichi HaraPathology
International
201767503-509

2016年

題名著者共著者雑誌
出血・狭窄のないStageⅣ胃癌に対する減量手術藤谷和正水澤純基、寺島雅典、岩崎善毅、高金明典、吉川貴己、中村健一、黒川幸典、福田治彦、笹子三津留、辻仲利政外科784385-3892016
腹腔内洗浄細胞診陽性(CY1)胃がんに対する治療:S-1単独療法、S-1+CDDP療法、S-1+DTX療法、S-1+オキザリプラチン療法藤谷和正うまく続ける!消化管がん薬物療法の基本とコツ
大腸がん周術期におけるオリコペプチド製剤(PN-2)投与の安全性および有用性について:探索的無作為比較試験安枝明日香宮崎進、松田宙、林紀行、團野克樹、久保田勝、川田純司、山根泰子、隅元理香、藤谷和正、岩瀬和裕、伊藤壽記栄養50151-612016
膵癌術後S-1内服中に発生した悪性甲状腺炎の1例斉藤百合奈原尚志、辻江正徳、宮本敦史、浅岡忠史、山本和義、池永雅一、宮崎道彦、池田正孝、平尾素宏、藤谷和正、関本貢嗣、中森正二癌と化学療法435621-6232016
単孔式腹腔鏡下手術にて整復された原発性小腸軸捻転症の1例西村正成宮崎進、松田宙、團野克樹、本告正明、藤谷和正内視鏡外科学会雑誌214477-48120167
術前化学療法後RO切除できたpCR、ypStage I 胃癌に対する術後補助化学療法は必要か山本和義西川和宏、平尾素宏、藤谷和正、辻仲利政、植村守、三宅正和、濱直樹、宮本敦史、宮崎道彦、大宮英泰、池田正孝、高見康二、中森正二、関本貢嗣癌と化学療法43121929-1932201611
皮膚筋炎を合併した胃癌術後直腸転移の1例西川和宏松田宙、川田純司、藤谷和正、遠藤俊治、平尾素宏、山本和義、前田栄、植村守、三宅正和、濱直樹、宮本敦史、池田正孝、中森正二、関本貢嗣癌と化学療法43122401-2403201611
胃空腸、回腸横行結腸吻合術後に多次化学療法にて長期生存した切除不能進行胃癌の1例西川和宏高橋剛、川田純司、藤谷和正、遠藤俊治、平尾素宏、山本和義、前田栄、植村守、三宅正和、濱直樹、宮本敦史、池田正孝、中森正二、関本貢嗣癌と化学療法43121926-1928201611
膵・胆管合流異常(先天性胆道拡張症)の過去、現在、未来中村哲郎大阪府総医医誌381-82016
腹部外傷を契機に発見されたsolid pseudopapillary tumor of the pancreasの1小児例三藤賢志髙間勇一、米田光宏、大野耕一、中岡達雄、東尾篤史、中村哲郎日本小児外科学会雑誌 521180-11852016

タイトル筆頭著者共著者雑誌 
C-reactive protein on postoperative day 3 as a predictor of infections complications following gastric cancer resectionY ShishidoK. Fujitani, K. Yamamoto, M.Hirao, T.Tsujinaka, M.SekimotoGastric Cancer201619293-301
Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA):a phase 3, randomised controlled trialK.FujitaniHan-KwangYang, J.Mizusawa, Young-Woo.Kim, M.Terashima, Sang-UK Han, Y.Iwasaki, Woo jin Hyng, Byung Joo Park, M.Sasako, T.Tsujinaka,for the REGATTAstudy investigatastLncet Oncol2016173309-18
Risk factorforsuperficial incisional surgical site infection after gastrectomy:analysis of patients enrolled in a prospective randomized trial skin closure methodsS.EndoT.Tsujinaka, K.Fujitani, J.Fujita, S.Tamura, M.Yamasaki, S.Kobayashi, Y.Akamaru, T.Mizuno, J.Shimizu, K.Umeshita, T.Ito, M.Mori, Y.DokiGastric Cancer201619639-644
Survival results of a randomised two-by-two factorial phase Ⅱtrial comparing neoadjuvant chemotherapy with two and four courses of S-1/cisplatin(SC)and paclitaxel/cosplatin(PC) followed by D2 gatrectomy for resectable advanced gastric cancerT.YoshikawaS.Morita, K.Tanabe, K.Nishida, Y.Ito, T.Matsui, K.Fujitani, Y.Kimura, J.Fujita, T.Aoyama, Y.Miyashita J.SakamotoEur J Cancer201662103-111
Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomyY.FukudaK.Yamamoto, M.Hirao, K.Nishikawa, Y.Nagatsuma, T.Nakayama, S.Tanikawa, S.Maeda, M.Uemura, M.Miyake, N.Hama, A.Miyamoto, M.Ikeda, S.Nakamori, M.Sekimoto, K.Fujitani, T.TsujinakaGastric Cancer201619986-993
A randomized phase Ⅱstudy of the clinical effects of ultrasonically activated coagulationg shears(Harmonic scalpel) in open gastrectomy for gastric cancerR.KawabataS.Takiguchi, Y.Kimura, H.Imamura, J.Fujita, S.Tamura, K.Fujitani, K.Kishi, K. Yamamoto, S.Fujiwara, Y.Kurokawa, M.Mori, Y.DokiSurg Today201646561-568
Early Detection and Treatment of Neuroblastic Tumor with Opsoclonus-Myoclonus Syndrome Improve Neurological Outcome: A Review of Five Cases at a Single Institution in Japan Takama YYoneda A, Nakamura T, Nakaoka T, Higashio A, Santo K, Kuki I, Kawawaki H, Tomiwa K, Hara JEur J Pediatr Surg,20162654-59

2015年

題名著者共著者雑誌
胃がん治療におけるConversion therapyの実際藤谷和正臨床腫瘍プラクティス11135-382015
術前化学療法後の胃癌切除標本における予後を最もよく反映する病理組織学的基準の設定藤谷和正胃がんperspective8148-502015
非治癒胃癌における緩和手術藤谷和正本告正明、中塚梨絵、川田純司、西川和宏、宮﨑進、團野克樹、久保田勝、松田宙、岩瀬和裕臨床外科70131468-14732015
妊娠15週の妊婦に対し腹腔鏡下虫垂切除術を施行した1例松浦記大團野克樹、松田宙、宮﨑進、久保田勝、藤谷和正日本内視鏡外科学会雑誌206635-640201511
術前治療により組織学的CRを得た進行直腸癌の2切除例松田宙團野克樹、宮﨑進、藤谷和正、久保田勝、本告正明、中塚梨絵、奥村雄一郎、野村雅俊、西村正成、北川彰洋、松浦記大、伏見博彰、岩瀬和裕癌と化学療法42122313-2315201511
FDG-PET 陽性で膵癌との鑑別が困難であった膵管内乳頭粘液腫瘍(IPMN)の1例久保田勝西村正成、中塚梨絵、宮﨑進、團野克樹、本告正明、松田宙、藤谷和正、岩瀬和裕癌と化学療法42122394-2396201511
イレウス解除術團野克樹消化器外科
NURSING
209796-79820159
鼠径ヘルニア手術團野克樹消化器外科
NURSING
209799-80020159
胸部食道切除術川田純司消化器外科
NURSING
20110-1320151
腸重積を併発した柿胃石イレウスの1例野口侑記岩瀬和裕、田中康博、藤谷和正外科774451-4552015
胃空腸バイパス手術症例における術前予後指標の検討西川和宏川田純司、福田泰也、山本和義、平尾素宏、藤谷和正、吉田洋、岩瀬和裕、田中康博、遠藤俊治、原田百合奈、原口直紹、三宅正和、浅岡忠史、宮本敦史、宮﨑道彦、池田正孝、中森正二、関本貢嗣外科と代謝49295-992015
異所性胃粘膜から発生したMeckel憩室癌の1例奥村雄一郎宮﨑進、藤谷和正、伏見博彰、團野克樹、松田宙日本臨床外科学会雑誌7692231-22362015
血便を主訴に来院し腹部CT検査にて門脈内ガスを認めた出血性腸炎の乳児例三藤賢志中村哲郎,大野耕一,中岡達雄,高間勇一,東尾篤史小児外科474435-4382015
超低出生体重児の消化管穿孔に対するループ式腸瘻造設術の工夫 当院で施行しているsutureless fascial and skin bridge loop enterostomy高間勇一中村哲郎,米田光宏,中岡達雄,東尾篤史,三藤賢志,本田優子小児外科47121284-12882015

タイトル筆頭著者共著者雑誌 
Multicenter randomized phase Ⅱ clinical trial of oxaliplatin reintroduction as a third -or-later-line therapy for metastatic colorectal cancer--biweekly versus standard triweekly XELOX(The ORION Study)Chu MatsudaMichitaka Honda,Chihiro Tanaka,Mutsumi Fukunaga,Keiichiro Ishibashi,Yoshinori Munemoto,Taishi Hata,Hiroyuki Bando,Mitsuru Oshiro,Michiya Kobayashi,Yukihiko Tokunaga,Akitomo Fujii,Naoki Nagata,Koji Oba,Hideyuki MishimaInt J Clin Oncol2015Oct
Double-Blind,Placebo-Controlled,Randomized Phase ⅡStudy of TJ-14(Hangeshashinto)for Infusional Flourinated-Pyrimidine-based Colorectal Cancer Chemotherapy-induced Oral MucositisChu MatsudaYoshinori Munemoto,Hideyuki Mishima,Naoki Nagata,Mitsuru Oshiro,Masato Kataoka,Junichi Sakamoto,Toru Aoyama,Satoshi Morita,Toru KonoCancer Chemother Pharmacol2015May
Randomaized Phase Ⅱstudy of S-1dosing schedule for resected colorectal cancer.Chu MatsudaMamoru Uemura,Ken Nakata,Tatsushi Shingai,Junichi Nishimura,Taishi Hata,Masakazu Ikenaga,Ichiro Takemasa,Tsunekazu Mizushima,Takeshi Kato,Masataka Ikeda,Masayuki Ohue,Kohei Murata,Junichi Hasegawa,Taroh Satoh,Hirofumi Yamamoto,Mitsugu Sekimoto,Riichiro Nezu,Yuichiro Doki and Masaki MoriBMC Cancer201515452
Intraoperative photodynamic diagnosis of lymph node metastasis in esophageal cancer patients using 5-aminolevulinic acidMASAAKI MOTOORIMASAHIKO YANO,KOJI TANAKA,KENTARO KISHI,HIDENORI TAKAHASHI,MASAHIRO INOUE,TAKURO SAITO,KEIJIRO SUGIMURA,YOSHIYUKI FUJIWARA,OSAMU ISHIKAWA,and MASATO SAKONONCOLOGY LETTERS 102015Nov1053035-3039
Randomaized study of the effect of synbiotics during neoadjuvant chemotheraph on adverse events in esophageal cancer patients.Motoori MYano M,Miyata H,Sugimura K,Saito t,Omori t,Fujiwara Y,Miyoshi N,Akita H,Gotoh K,Takahashi H,Kobayashi S,Noura S,Ohue M,Asahara T,Nomoto K,Ishikawa O,Sakon MClin Nutr.2015Nov
Gene therapy with SOCS1 for gastric cancer induces G2/M arrest and has an antitumour effect on peritoneal carcinomatosisRie NakatsukaTsuyoshi Takahashi,Satoshi Serada,Minoru Fujimoto,Tomohiro Ookawara,Toshirou Nishida,Hisashi Hara,Takahiko Nishigaki,Emi Harada,Takashi Murakami,Yasuhiro Miyazaki,Tomoki Makino,Yukinori Kurokawa,Makoto Yamasaki,Hiroshi Miyata,Kiyokazu Nakajima,Shuji Takiguchi,Tadamitsu Kishimoto,Masaki Mori,Yuichiro Doki, and Tetsuji NakaBritish Journal of Cancer2015113433-442
Phase ⅡStudy of Oral Tegafur/Uracil and Leucovorin plus Bevacizumab as a First-Line Therapy for Elderly Patients with Advanced or Metastatic Colorectal CancerMizushima TTamagawa H,Matsuda C,Murata K,Fukunaga M,Ota H,Hasegawa J,Tsujie M,Fukuzaki T,Hata T,Takemasa I,Ikeda M,Yamamoto H,Sekimoto M,Nezu R,Doki Y,Mori MONCOLOGY 2015May893152-8
Observation of the rare B(s)(0)→μ+μ-decay from the combined analysis of CMS and LHCb dataMasaru Kubota,
Collaborators(2829)
Nature20152016-06-04 00:00:00522755468-72
Effects of Daikenchuto,a Japanese Herb,on Intestinal Motility After Total Gastrectomy:a Prospective Randomized TrialYusuke AkamaruTsuyoshi Takahashi,Toshirou Nishida,Takeshi Omori,Kazuhiro Nishikawa,Shoki Mikata,Noriyuki Yamamura,Satoru Miyazaki,Hiroshi Noro,Shuji Takiguchi,Masaki Mori,Yuichiro DokiJ Gastrointest Surg2015Jan19467-472
Our experience of treating undifferentiated gastric carcinoma:report of four casesSunji EndoKazuhiro Nishikawa,Terumasa Yamada,Tomo Nakagawa,Hiroaki Fushimi,Tsuyoshi Chihara,Amane Yamauchi,Junichi NishijimaSurg Today201545235-240
Randomized phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy:TRICS trialK.NisikawaK.Fujitani, H.Inagaki, Y.Akamaru, S.Tokunaga, M.Takagi, S.Tamura, N.Sugimoto, S.Morita, Y.Miyashita, A.Tsuburaya, J.Sakamoto, T.TsujinakaEur J Cancer201551808-816
Skeletal muscle loss after total gastrectomy,exacerbated by adjuvant chemotherapyY.YamaokaK.Fujitani, T.Tsujinaka, K.Yamamoto, M.Hirao, M.SekimotoGastric Cancer201518382-389
Prevalence of malnutrition among gastric cancer patients undergoing gastrectomy and optimal preoperative nutritional support for preventing surgical site infectionsY. FukudaK.Yamamoto, M. Hirao, K. Nishikawa, S.Maeda, N.haraguchi, M.Miyake, N.Hama, K.Fujitani and T.TsujinakaAnn Surg Oncol2015322778-785
Early detection and treatment of neuroblastic tumor with opsoclonus-myoclonus syndrome improve neurological outcome: A review of five cases at a single institution in JapanYuichi Takama, Akihiro Yoneda, Tetsuro Nakamura, Tatsuo Nakaoka, Atsushi Higashio, Kenji Santo, Ichiro Kuki, Hisashi Kawawaki, Kiyotaka Tomiwa, Junichi HaraEur J Pediatr Surg2015Sep 26.
Focal form of congenital hyperinsulinism clearly detectable by contrast-enhanced computed tomography imagingYukiko Hashimoto, Azumi Sakakibara,Rie Kawakita,Yuki Hosokawa,Rika Fujimaru,Tetsuro Nakamura,Hiroko Fukushima,Aiko Igarashi,Michiya Masue,Hironori Nishibori,Nobuyoshi Tamagawa,Akiko Murakami,Kazue Hatake and Tohru YorifujiInternational Journal of Pediatric Endocrinology201520
Effects of the Cessation of Mass Screening for Neuroblastoma at 6 Months of Age:A Population-Based Study in Osaka,JapanIoka AInoue M,Yoneda A,Nakamura T,Hara J,Hashii Y,Sakata N,Yamato K,Tsukuma H,Kawa K.J Epidemiol2015Nov.7
Isolated Diffuse Hemangiomatosis of the Spleen with Disseminated Intravasular Coagulation:Successful Treatment with Embolization and SplenectomyYoshiko NakanoHiroyuki Fujisaki,Tomoya Ishiguro,Takao Manabe,Takeshi Inoue,Young-Dong Park,Tetsuro Nakamura,Junichi HaraTHE JOURNAL OF PEDIATRICS20151661093

2014年

題名著者共著者雑誌
切除可能進行胃癌に対する術前補助化学療法の取り組み藤谷和正Approach to Oncology104-620142
大腸癌術後補助化学療法におけるXELOX療法の認容性について松田宙團野克樹、宮崎進、藤谷和正、久保田勝、川田純司、高木麻里、福井亜希子、岩瀬和裕、田中康博癌と化学療法416743-74720146
75歳以上の胃癌症例に対する化学療法川田純司松浦記大、北川彰洋、西村正成、野村雅俊、奥村雄一郎、宮﨑進、團野克樹、久保田勝、松田宙、大森謙一、西川和宏、野村昌哉、高木麻里、福井亜希子、藤谷和正、岩瀬和裕、田中康博癌と化学療法41122248-2250201411
30.先天性胆道拡張症中村哲郎高間勇一小児外科診療ハンドブック実地診療に役立つ周術期管理と手術のポイント378-3862014
15.小腸閉鎖症中村哲郎高間勇一小児外科診療ハンドブック実地診療に役立つ周術期管理と手術のポイント253-2612014
鼠径管アプローチによるヘルニア修復術習得に必要な手術執刀数:腹腔鏡下鼠径ヘルニア修復術導入後の問題点大野耕一中村哲郎、中岡達雄、高間勇一、東尾篤史、三藤賢志日小外会誌50211-2162014
小児会陰部杭創の2例出口幸一吉田洋、梅田聡、野口侑記、田中康博日本小児外科学会雑誌5081-852014
早めの手術で治る鼠径ヘルニア吉田洋大阪府立急性期・総合医療センターの最新治療がわかる本166-1672014
33.臍ヘルニア 尿膜管遺残吉田洋小児外科診療ハンドブック実地診療に役立つ周術期管理と手術のポイント402-4072014

タイトル筆頭著者共著者雑誌 
Three-year outcomes of a phase Ⅱstudy of adjuvant chemotherapy with S-1 plus docetaxel for Stage Ⅲ gastric cancer after curative D2 gastrectomyFujitani KTamura S,Kimura Y,Tsuji T,Matsuyama J,Iijima S,Imamura H,Inoue K,Kobayashi K,Kurokawa Y,Shimokawa T,Tujinaka T,Furukawa HGastric Cancer2014172348-353
Skeletal muscle loss after total gastrectomy,exacerbated by adjuvant chemotherapyFujitani KYamaoka Y,Tujinaka T,Yamamoto K,Hirao M,Sekimoto MGastric Cancer20142015-04-09 00:00:00
Optimal treatment change criteria for advanced gastric cancer with non-measurable peritoneal metastaasis:symptom/tumor marker-based versus CT-basedFujitani KHasegawa H,Nakazuru S,Hirao M,Yamamoto K,Mita E,Tujinaka TAnticancer Research20143495169-5174
Surgical resection of hepatic metastasis from gastric cancer:a review and new recommendation in the Japanese gastric cancer treatment guidelinesKodera YFujitani K,Fukushima N,Ito S,Muro K,Ohashi N,Yoshikawa T,Kobayashi D,Tanaka C,Fujiwara MGastric Cancer2014172206-212
Randomized phase Ⅱtrial of S-1 plus irinotecan versus S-1 plus paclitaxel as first-line treatment for advanced gastric cancer (OGSG0402)Sugimoto NFujitani K,Imamura H,Uedo N,Iijima S,Imano M,Shimokawa T,Kurokawa Y,Furukawa H,Goto MAnticancer Research2014342851-857
Japan Esophageal Oncology Group/Japan Clinical Oncology Group.Phase Ⅰ/Ⅱtrial of 2-weekly docetaxel combined with cisplatin plus fluor ouracil in metastatic esophageal cancer(JCOG0807)Hironaka STsubosa Y,Mizusawa J,Kii T,Kato K,Tsushima T,Chin K,Tomori A,Okuno T,Taniki T,Ura T,Matsushita H,Kojima T,Doki Y,Kusaba H,Fujitani K,Taira K,Seki S,Nakamura T,Kitagawa YCancer Science201410591189-1195
Randomized controlled trial of the LigaSure vessel sealing system versus conventional open gastrectomy for gastric cancerFujita JTakiguchi S,Nishikawa K,Kimura Y,Imamura H,Tamura S,Ebisui C,Kishi K,Fujitani K,Kurokawa Y,Mori M,Doki Y
Surgery Today20144491723-1729
Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancerY. YamadaK. Higuchi, K. Nishikawa, M. Gotoh, N. Fuse, N. Sugimoto, T. Nishina, K. Amagai, K. Chin, Y. Niwa, A. Tsuji, H. Imamura, M. Tsuda, H. Yasui,
H. Fujii, K. Yamaguchi, H. Yasui, S. Hironaka, K. Shimada, H. Miwa, C. Hamada and I. Hyodo
Ann Oncol
Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.Tsuburaya AYoshida K, Kobayashi M, Yoshino S, Takahashi M, Takiguchi N, Tanabe K, Takahashi N, Imamura H, Tatsumoto N, Hara A, Nishikawa K, Fukushima R, Nozaki I, Kojima H, Miyashita Y, Oba K, Buyse M, Morita S, Sakamoto J.Lancet Oncol.2014Jun158886-93
Low creatinine clearance is a risk factor for D2 gastrectomy after neoadjuvant chemotherapy.Hayashi TAoyama T, Tanabe K, Nishikawa K, Ito Y, Ogata T, Cho H,
Morita S, Miyashita Y, Tsuburaya A, Sakamoto J, Yoshikawa T
Ann Surg Oncol2014Sep2193015-22
Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis.Aoyama TNihsikawa K, Takiguchi N, Tanabe K, Imano M, Fukushima R, Sakamoto J, Oba M, Morita S, Kono T, Tsuburaya ACancer Chemother Pharmacol2014May7351047-54
Accuracy of CT Staging of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy:
Cohort Evaluation within a Randomized Phase II Study.
Yoshikawa TTanabe K, Nishikawa K, Ito Y, Matsui T, Kimura Y, Hasegawa S,
Aoyama T, Hayashi T, Morita S, Miyashita Y, Tsuburaya A, Sakamoto J
Ann Surg Oncol2014Jun21Suppl 3S385-9
Our experience of treating undifferentiated gastric carcinoma: report of four cases.Endo SNishikawa K, Yamada T, Nakagawa T, Fushimi H, Chihara T, Yamauchi A, Nishijima JSurg Today
Efficacy of endoscopic gastroduodenal stenting for gastric outlet obstruction due to unresectable advanced gastric cancer: A prospective multicenter study.Endo STakiguchi S, Miyazaki Y, Nishikawa K, Imamura H, Takachi K, Kimura Y,
Takeno A, Tamura S, Mori M, Doki Y; CLINICAL STUDY GROUP OF OSAKA UNIVERSITY (CSGO), UPPER GI GROUP.
J Surg Oncol.2014Mar1093208-12
Induction of a Pathological Complete Response by Four Courses of Neoadjuvant Chemotherapy for Gastric Cancer: Early Results of the Randomized Phase II COMPASS Trial.Yoshikawa TTanabe K, Nishikawa K, Ito Y, Matsui T, Kimura Y, Hirabayashi N, Mikata S, Iwahashi M, Fukushima R, Takiguchi N, Miyashiro I, Morita S, Miyashita Y, Tsuburaya A, Sakamoto JAnn Surg Oncol2014Jan211213-219
Multicenter PhaseⅡStudy of Second-line Cetuximab plus Folinic Acid/5-Fluorouracil/Irinotecan(FOLFIRI) in KRAS Wild-type Metastatic Colorectal Cancer:The FLIER StudyIwamoto SHazama S,Kato T,Miyake Y,Fukunaga M,Matsuda C,Bando H,Sakamoto J,Oba KANTICANCER RESEARCH2014341967-1974